Company & Sponsor Intelligence

University of California, Los Angeles

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials42
Recruiting8
Completed29
Countries2

Therapeutic footprint

adhdalzheimersanxietyautismbipolar_disorderdepressionepilepsyintellectual_disabilityneurodevelopmental_otherother_neurologyother_psychiatryptsdstrokesubstance_use

Indexed studies

NCT04387435Optimization of VNS in Epileptic Patients to Induce Cardioprotection
epilepsy · United States
NA
NCT04385498Primary Care Intervention for PTSD in Ethiopia
ptsd · Ethiopia
NA
NCT01388530Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
adhd · United States
EARLY_PHASE1
NCT06036420Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing
adhd · United States
NA
NCT03153371Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
alzheimers · United States
COMPLETED
NCT03790280High Frequency Oscillation in Pediatric Epilepsy Surgery
epilepsy · United States
NA
NCT01122329A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease
alzheimers · United States
PHASE4
NCT05499741Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder
neurodevelopmental_other · United States
NA
NCT03827265Transcranial Magnetic Stimulation and Tobacco Use Disorder
other_psychiatry · United States
NA
NCT06597942Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
alzheimers · United States
PHASE1, PHASE2
NCT03117530Measuring Brain Inflammation in Autism
autism · United States
PHASE1
NCT07219875Training Reward Responsiveness Through Virtual Reality
depression · United States
PHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →